1) Neurologic impairment score
神经功能缺损评分
1.
After one course of treatment,clinical treatment effect,neurologic impairment score pre-and post-therapy and hemorheological change in two groups were.
1个疗程后比较两组临床疗效、神经功能缺损评分和血液流变学的变化。
2) NDS
神经功能缺损评分
1.
[Re- sults] Of the treated group, the neurological deficit scale scores (NDS) 9.
[结果]治疗组治疗后神经功能缺损评分(NDS)9。
3) NIHSS
神经功能缺损评分
1.
Methods The subjects included 291 acute stroke inpatients, whose demographic characteristics, risk factors of stroke, severity degree like ocular movement disturbance, aphasia, dysphagia, urinary incontinence (UI), GCS, NIHSS, BI and types of stroke were recorded.
方法以首发脑卒中住院的急性患者为研究对象,记录其人口特征,脑卒中危险因素,最初脑卒中严重性如眼球运动障碍、失语、吞咽困难、尿失禁(UI)、格拉斯哥昏迷评分(GCS),神经功能缺损评分(NIHSS),日常生活能力评分(BI)及脑卒中类型;3月后随访其功能康复情况:牛津残障评分(OHS),并分析影响脑卒中预后的相关危险因素。
2.
At the same time the neurological deficits states were evaluated by the national institute of health stroke scale(NIHSS).
方法应用ELISA动态观察52例ACI患者血清vWF的变化,并与52例健康对照者对比,同时应用NIHSS进行神经功能缺损评分。
4) neurological deficit score
神经功能缺损评分
1.
Neurological deficit scores in each group were lower after treatment than before,but there were no significant differences between each group(P > 0.
比较治疗前后血脂、神经功能缺损评分、生化指标等变化,并记录服药后不良反应。
2.
Objective To explore the relationship of clinical syndrome standards, neurological deficit score and laboratory diagnosis indicators in cerebral infarction identified as wind syndrome caused by hyperactive liver yang.
结论神经功能缺损评分和实验诊断指标能显著提高临床辨证标准的客观性,建立证候积分、神经功能缺损评分和4项实验诊断指标的综合辨证标准有临床使用价值。
5) Scandinavian stroke scale
神经功能缺损评分
1.
Result:Scandinavian stroke scales were obviously improved after 14 days; Hemorheologys were also changed markedly (P<0.
方法:对60例急性脑梗死患者给予标准疗程的巴曲酶治疗,评定治疗前后的神经功能缺损评分,血液流变学指标。
2.
Methods Standard courses of batroxobin were given for 40 patients with progressive cerebral infarction,scandinavian stroke scale,hemorheology and therapeutic effect were assessed before and after treatment.
方法对40例进展性脑梗塞患者给予标准疗程的巴曲酶治疗,评定治疗前后的神经功能缺损评分、血液流变学指标及总体疗效。
补充资料:人体功能状况评分
人体功能状况评分
人体功能状况评分标准以Karnofsky(KPS)评分和ZubrodECOGWHO评分常用,其计分标准如下:①Karnofsky(KPS)评分:评分为100者正常,无症状及体征;评分为90者能进行正常活动,有轻微症状及体征;评分为80者勉强可进行正常活动,有一些症状或体征;评分为70者生活可自理,但不能维持正常生活或工作;评分为60者有时需人扶助,但大多数时间可自理;评分为50者常需人照料;评分为40者生活不能自理,需特别照顾;评分为30者生活严重不能自理;评分为20者病重,需住院积极支持治疗;评分为10者病危,临近死亡;评分为0者死亡。②ZubrodECOGWHO(ZPS)评分:0正常活动;1有症状,但几乎完全可自由活动;2有时卧床,但白天卧床时间不超过50%;3需要卧床,卧床时间白天超过50%;4卧床不起;5死亡。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条